Search

everythinglearnresearchcommunity

for

Search:↓

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

Endocrine therapy helps with reproductive and metabolic issues in women with PCOS.

Different types of polycystic ovary syndrome show varying levels of insulin resistance, with the 'PHO' type being the most insulin resistant.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Many young Egyptian women with PCOS also have fatty liver disease, especially if they are overweight and insulin resistant.

Insulin resistance plays a key role in PCOS, and lifestyle changes, weight loss, and medications like metformin can help manage it.

Metformin helps induce ovulation in obese women with PCOS, but weight loss is still the main treatment.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

No true link between AGA and insulin resistance, but coexistence may worsen AGA.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Taking metformin with intense pulsed light therapy improves hair removal for women with PCOS.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

There's no significant link between the D19S884 marker at the insulin receptor gene and polycystic ovary syndrome.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

Insulin resistance is not more common in idiopathic hirsutism patients than in healthy individuals.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

Early balding men may have insulin resistance, but lifestyle changes can help.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.